These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4262647

  • 21. [Activity of enzymes of intermediate protein metabolism in thio-TEPA treatment of patients with ovarian cancer].
    Lushnikova MV.
    Vopr Onkol; 1974 Oct; 20(7):96-7. PubMed ID: 4212533
    [No Abstract] [Full Text] [Related]

  • 22. High dose thiotepa in ovarian cancer.
    Shetty PA, Kurkure PA, Pai VR, Gohokar D, Pai S, Shinde SR, D'Souza LJ, Sampat MB.
    Indian J Cancer; 1985 Mar; 22(1):33-7. PubMed ID: 3939232
    [No Abstract] [Full Text] [Related]

  • 23. Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.
    Hagen B, Walseth F, Walstad RA, Iversen T, Nilsen OG.
    Cancer Chemother Pharmacol; 1987 Mar; 19(2):143-8. PubMed ID: 3105905
    [Abstract] [Full Text] [Related]

  • 24. Chemotherapy of ovarian cancer with melphalan.
    Rutledge F.
    Clin Obstet Gynecol; 1968 Jun; 11(2):354-66. PubMed ID: 4971815
    [No Abstract] [Full Text] [Related]

  • 25. [A cytogenetic analysis of variants of a strain of rat ovary tumors resistant to 6-mercaptopurine and thio-TEPA].
    Voitovitskii VK, Edygenova AK, Kabiev OK.
    Vopr Onkol; 1970 May; 16(5):87-92. PubMed ID: 4988932
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Histochemical characteristics of epithelial bladder tumors].
    Enokhovich VA.
    Vopr Onkol; 1972 May; 18(5):27-33. PubMed ID: 4261410
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E, Zitron S, Nissenkorn I, Servadio C.
    Isr J Med Sci; 1980 May; 16(9-10):714-6. PubMed ID: 6776072
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [In-vitro metaboli studies on normal human ovaries, benign and malignant ovarian tumors].
    Hackl H.
    Arch Gynakol; 1967 May; 204(4):167-77. PubMed ID: 5631017
    [No Abstract] [Full Text] [Related]

  • 37. Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response.
    Deligdisch L, Jacobs AJ, Cohen CJ.
    Am J Obstet Gynecol; 1982 Dec 15; 144(8):885-9. PubMed ID: 6890770
    [Abstract] [Full Text] [Related]

  • 38. [Therapy of urinary bladder tumors].
    Rabkova LM.
    Vopr Onkol; 1967 Dec 15; 13(9):52-8. PubMed ID: 4971095
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Cytostatic treatment of genital carcinoma].
    Limburg H.
    Zentralbl Gynakol; 1969 Sep 13; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.